◼ Archived
Business
🔮 fades
The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High
Arrowhead Pharmaceuticals shares surge following positive Phase 3 clinical trial results for its triglyceride lowering drug, plozasiran.